Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma

INTRODUCTION: GP88 (progranulin) has been implicated in tumorigenesis and resistance to anti-estrogen therapies for estrogen receptor positive (ER(+)) breast cancer. Previous pathological studies showed that GP88 is expressed in invasive ductal carcinoma (IDC), but not in normal mammary epithelial t...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Serrero, Ginette, Hawkins, Douglas M, Yue, Binbin, Ioffe, Olga, Bejarano, Pablo, Phillips, Jeffrey T, Head, Jonathan F, Elliott, Robert L, Tkaczuk, Katherine R, Godwin, Andrew K, Weaver, JoEllen, Kim, Wes E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2012
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3496144/
https://ncbi.nlm.nih.gov/pubmed/22316048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr3111
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak